Becton Dickinson (XSWX:BDX) Long-Term Debt: CHF11,578 Mil (As of Mar. 2026)


XSWX:BDX Becton Dickinson & Co XSWX:BDX
77 GF Score
Price CHF125.66
GF Value CHF151.22
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Long-Term Debt?

Becton Dickinson XSWX:BDX +0.45% 77 Long-Term Debt is CHF11,578 Mil as of Mar. 2026. GuruFocus rates XSWX:BDX with a GF Score™ of 77/100 and a GF Value™ of CHF151.22. The stock has 3 warning signs investors should review.

Becton Dickinson's Long-Term Debt for the quarter that ended in Mar. 2026 was CHF11,578 Mil.

Becton Dickinson's quarterly Long-Term Debt declined from Sep. 2025 (CHF14,028 Mil) to Dec. 2025 (CHF13,480 Mil) and declined from Dec. 2025 (CHF13,480 Mil) to Mar. 2026 (CHF11,578 Mil).

Becton Dickinson's annual Long-Term Debt increased from Sep. 2023 (CHF13,258 Mil) to Sep. 2024 (CHF15,199 Mil) but then declined from Sep. 2024 (CHF15,199 Mil) to Sep. 2025 (CHF14,028 Mil).

Becton Dickinson  (XSWX:BDX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Becton Dickinson Long-Term Debt Related Terms

Becton Dickinson Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Long-Term Debt Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,789.11 13,515.24 13,258.31 15,198.77 14,028.08

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,609.68 14,256.21 14,028.08 13,480.36 11,578.03
XSWX:BDX
77GF Score
Becton Dickinson & Co XSWX:BDX
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF11,578 Mil mean?
Becton Dickinson (XSWX:BDX) has a Long-Term Debt of CHF11,578 Mil as of Mar. 2026.
Is Becton Dickinson's Long-Term Debt too high?
Becton Dickinson's current Long-Term Debt is CHF11,578 Mil. Overall, Becton Dickinson has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Long-Term Debt compare to MDLN and RMD?
Becton Dickinson's Long-Term Debt of CHF11,578 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Becton Dickinson's current Long-Term Debt is CHF11,578 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current Long-Term Debt of CHF11,578 Mil. The stock's GF Value™ is CHF151.22, compared to a current price of CHF125.66 — trading 16.9% below its estimated fair value. The current Long-Term Debt is CHF11,578 Mil. Becton Dickinson's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current Long-Term Debt is CHF11,578 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF125.66 is trading 16.9% below its estimated GF Value™ of CHF151.22.

Key valuation signals for XSWX:BDX:

  • Long-Term Debt: CHF11,578 Mil
  • GF Value™: CHF151.22 vs. price of CHF125.66 (16.9% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score

Get the complete analysis for XSWX:BDX

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF125.66
Price
CHF151.22
GF Value